Table 1.
Subgroup analysis by diagnosis (n, %) |
Subgroup analysis by willingness (n, %) |
|||||
---|---|---|---|---|---|---|
GGO | Lung cancer | P | High | Low | P | |
Age (Mean±SD) | 49.6 ± 9.9 | 50.1 ± 9.7 | 0.706 | 50.4 ± 9.2 | 49.3 ± 10.4 | 0.295 |
Gender | <0.001 | <0.001 | ||||
Male | 49 (23.3) | 47 (41.2) | 62 (41.1) | 34 (19.7) | ||
Female | 161 (76.7) | 67 (58.8) | 89 (58.9) | 139 (80.3) | ||
Education level | 0.297 | 0.819 | ||||
Middle school diploma or below | 24 (11.4) | 23 (20.2) | 20 (13.3) | 27 (15.6) | ||
High school diploma or equivalent | 96 (45.7) | 44 (38.6) | 67 (44.4) | 73 (42.2) | ||
College diploma and above | 90 (42.9) | 47 (41.2) | 64 (42.4) | 73 (42.2) | ||
Comorbidities | ||||||
Hx of allergy to drug/food | 14 (6.7) | 12 (10.5) | 0.222 | 14 (9.3) | 12 (6.9) | 0.4402 |
Hx of allergy to vaccine/s | 0 | 0 | − | 0 | 0 | − |
Hypertension | 35 (16.7) | 13 (11.4) | 0.203 | 20 (13.3) | 28 (16.2) | 0.457 |
Diabetes mellitus | 7 (3.3) | 5 (4.4) | 0.759* | 9 (5.2) | 3 (2.0) | 0.126* |
Coronary artery diseases | 3 (1.4) | 1 (0.9) | 1.000* | 2 (1.2) | 2 (1.3) | 1.000* |
Chronic dermatosis | 10 (4.8) | 3 (2.6) | 0.555* | 6 (4.0) | 7 (4.1) | 0.974 |
COPD | 0 | 0 | − | 0 | 0 | − |
Chronic communicable diseases | 6 (2.9) | 9 (7.9) | 0.039 | 7 (4.6) | 8 (4.6) | 0.996 |
Hematological malignancy | 0 | 0 | − | 0 | 0 | − |
Immunodeficiency diseases | 1 (0.5) | 0 | 1.000* | 0 | 1 (0.6) | 1.000* |
Other Hx of malignancy | 24 (11.4) | 9 (7.9) | 0.315 | 12 (8.0) | 21 (12.1) | 0.013 |
Diagnosis | − | <0.001 | ||||
GGO | 210 (100) | 0 | 113 (74.8) | 97 (56.1) | ||
Lung cancer | 0 | 114 (100) | 38 (25.2) | 76 (43.9) | ||
Willingness for vaccination | <0.001 | − | ||||
Completely refuse | 6 (2.9) | 14 (12.3) | − | 20 (7.6) | ||
Hesitant | 91 (43.3) | 62 (54.4) | − | 153 (58.4) | ||
Acceptable | 40 (19.0) | 23 (20.2) | 63 (41.7) | − | ||
Intend to receive | 18 (8.6) | 8 (7.0) | 26 (17.2) | − | ||
Already vaccinated | 55 (26.2) | 7 (6.1) | 62 (41.1) | − |
*Fisher’s exact test. GGO, ground-glass opacity; COPD, chronic obstructive pulmonary disease; SD, standard deviation; Hx, history.